MedX Health Expands UK Presence with Health Partners Agreement

MedX Health ( (TSE:MDX) ) has provided an announcement.

MedX Health Corp. has signed a commercial agreement with Health Partners Group, the UK’s largest occupational health services provider, to roll out its DermSecure® skin cancer screening platform following a successful pilot. This collaboration aims to provide rapid, non-invasive skin cancer assessments to thousands of at-risk employees, particularly outdoor and industrial workers, significantly reducing diagnosis times and enhancing preventive care in the workplace.

More about MedX Health

MedX Health Corp., based in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. Their proprietary SIAscopy® technology, integrated into the DermSecure® platform, allows for pain-free, accurate imaging of skin lesions for rapid dermatologist review. The company’s products are approved for use in multiple countries, including Canada, the U.S., and the UK.

Average Trading Volume: 83,183

Technical Sentiment Signal: Sell

Current Market Cap: C$18.01M

For a thorough assessment of MDX stock, go to TipRanks’ Stock Analysis page.